Related Experiment Video
Updated: Jun 14, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Carotid intima-media thickness in patients with end-stage renal disease
K Sunil Kumar1, A Y Lakshmi, P V L N Srinivasa Rao
1Department of Nephrology, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
Insights
Patients with end-stage renal disease (ESRD) show higher carotid intima-media thickness (CIMT), a marker of atherosclerosis, and increased oxidative stress. This noninvasive measurement is valuable for assessing cardiovascular risk in chronic kidney disease patients.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Accelerated atherosclerosis and cardiovascular disease are leading causes of death in end-stage renal disease (ESRD) patients.
- Carotid intima-media thickness (CIMT) serves as a reliable indicator of atherosclerosis.
- Oxidative stress is implicated in the pathogenesis of cardiovascular complications in ESRD.
Purpose of the Study:
- To investigate carotid intima-media thickness (CIMT) in end-stage renal disease (ESRD) patients before dialysis initiation.
- To assess the relationship between CIMT and markers of oxidative stress in ESRD.
- To evaluate CIMT as a diagnostic tool for atherosclerosis in chronic kidney disease.
Main Methods:
- Ultrasonography was used to measure CIMT in 30 ESRD patients prior to dialysis.
- Serum oxidative stress markers were quantified in ESRD patients and compared to controls.
- CIMT measurements were compared between ESRD patients and a control group.
Main Results:
- ESRD patients exhibited significantly higher CIMT compared to the control group.
- Elevated levels of serum oxidative stress markers were observed in ESRD patients.
- A correlation between increased CIMT and heightened oxidative stress was suggested.
Conclusions:
- CIMT is elevated in ESRD patients, indicating accelerated atherosclerosis.
- Increased oxidative stress is present in ESRD patients.
- CIMT is a practical, noninvasive, and cost-effective method for evaluating atherosclerosis in chronic renal failure.
Abstract:
Accelerated atherosclerosis and cardiovascular disease are major causes of morbidity and mortality in patients of end-stage renal disease. Carotid intima media thickness is taken as a useful surrogate marker of atherosclerosis. Thirty end-stage renal disease (ESRD) patients were subjected to ultrasonography to study CIMT before the initiation of dialysis. CIMT was found to be higher in ESRD patients than in controls. Levels of a serum marker of oxidative stress were also found to be higher in patients than in the controls. CIMT is an easy, noninvasive, reproducible, and cost-effective investigation in patients with chronic renal failure.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
